CD4 and neoplasm: In general, PANoptosis-related high-risk group had a higher proportion of tumor-promoting immune cells (M2 macrophages and Tregs) and a lower proportion of antitumor immune cells (plasma cells, CD4+ naive cells and activated NK cells).